Phase I single ascending dose trial of FAB 001 in healthy volunteers.

Trial Profile

Phase I single ascending dose trial of FAB 001 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs FAB 001 (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 05 Jun 2017 Results presented at the ASM Microbe 2017
    • 03 Oct 2012 New trial record
    • 07 May 2011 Trial results reported at the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top